Platelet‐Rich Plasma Therapy for Refractory Skin Ulcers: A Case Series of 12 Patients and Concise Review of the Literature
The Journal of Dermatology · 2026-08 · 53 (8) · 1208-1212
DOI: 10.1111/1346-8138.70365 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Dermatology, online erschienen am 19.06.2026. Verfasst von Teruhiko Makino und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Skin Ulcer. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Chronic skin ulcers remain a significant therapeutic challenge, particularly in patients with underlying medical conditions, and often prove difficult to treat with conventional methods. Platelet‐rich plasma (PRP), an autologous preparation rich in growth factors, has garnered attention as a promising treatment option; however, its clinical efficacy remains inconsistent. In this study, we retrospectively evaluated 12 patients with refractory skin ulcers who received PRP therapy between 2018 and 2023. PRP was prepared from the patients' own blood and administered once weekly for 4 weeks; treatment efficacy was assessed based on the rate of reduction in ulcer area. Clinical outcomes varied depending on the etiology of the ulcer. Marked improvement was observed in patients with livedoid vasculopathy and burn‐related ulcers, whereas moderate to marked improvement was seen in diabetic ulcers only when peripheral blood flow was preserved. In contrast, the response was minimal or absent in ulcers associated with pressure ulcers or peripheral arterial disease. Importantly, no adverse events were observed during treatment. These findings suggest that PRP therapy is a safe and potentially effective option for refractory skin ulcers, particularly in non‐ischemic conditions. However, its efficacy appears to be limited in wounds involving ischemia or mechanical injury, highlighting the importance of appropriate patient selection and wound condition optimization. Further studies using standardized protocols are necessary to clarify its clinical indications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan.
ORCID-Profile: Teruhiko Makino, Keita Takemoto, Megumi Mizawa
Zitieren
APA
Makino, T., Takemoto, K., Mizawa, M., & Shimizu, T. (2026). Platelet‐Rich Plasma Therapy for Refractory Skin Ulcers: A Case Series of 12 Patients and Concise Review of the Literature. The Journal of Dermatology, 53(8), 1208-1212. https://doi.org/10.1111/1346-8138.70365
Vancouver
Makino T, Takemoto K, Mizawa M, Shimizu T. Platelet‐Rich Plasma Therapy for Refractory Skin Ulcers: A Case Series of 12 Patients and Concise Review of the Literature. The Journal of Dermatology. 2026;53(8):1208-1212. doi:10.1111/1346-8138.70365
BibTeX
@article{Makino2026,
author = {Makino, Teruhiko and Takemoto, Keita and Mizawa, Megumi and Shimizu, Tadamichi},
title = {Platelet‐Rich Plasma Therapy for Refractory Skin Ulcers: A Case Series of 12 Patients and Concise Review of the Literature},
journal = {The Journal of Dermatology},
year = {2026},
volume = {53},
number = {8},
pages = {1208--1212},
doi = {10.1111/1346-8138.70365}
}
EUVIMED